The main force continued to increase its position in lithium battery stocks in the late trading, and sold off banks and pharmaceutical stocks
The main funds continued to add plates such as nonferrous metals, semiconductors, computers and lithium batteries, selling medicine, banks, Baijiu, securities, coal and other sectors. Specifically, in terms of individual stocks, Ganfeng lithium industry closed its trading limit and received a main net inflow of 1.977 billion yuan; Salt Lake shares and Lixun precision received net inflows of 1.293 billion yuan and 901 million yuan respectively; Tianqi lithium industry, Jingao technology, Zhejiang digital culture, etc. all won the main warehouse increase of more than 700 million yuan. In terms of net outflow, Fosun Pharmaceutical and Guizhou Maotai suffered net outflow of 527 million yuan and 412 million yuan respectively; Perfect world, Jianfeng group, Bank of Lanzhou, Jishi media, China Merchants Bank and muyuan shares were all sold off by the main force of more than 200 million yuan.
This text is a result of machine translation.
Related companies：
Briefing Jun 28, 2022 12:29 PM
· Financials
Many banks have issued documents to stop the intelligent investment advisory business. Insiders: it may be restarted after the regulatory rules are released
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Briefing Jun 27, 2022 03:19 PM
· Financials
Mihayou v. Minmetals trust case will hold a court session, and it is difficult to recover the funds involved in the thunderstorm products
Jan 30, 2024 07:59 PM
Dec 11, 2023 08:49 PM
May 11, 2023 05:07 PM
Jan 06, 2023 08:30 AM
Briefing Jun 25, 2022 06:50 AM
In the half year, the 36billion yuan production expansion plan has been thrown away, and the competition in the stock market of Baijiu is fierce
Healthcare, Financials
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Briefing Jun 24, 2022 10:29 AM
· Consumer Staples
Dongbei group: the holding foundry subsidiary currently produces brake discs and other products at full capacity, with orders in short supply
Briefing Jun 20, 2022 01:54 PM
· Consumer Staples
Changes in the aquaculture sector pulled Fucheng shares up by the daily limit
Briefing Jun 17, 2022 11:03 AM
· Technology
SASAC: adjust and optimize the layout and structure of the state-owned economy and accelerate the construction of a world-class enterprise with global competitiveness
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
Chinese Cuisine Brand YGF Malatang Ventures into Brazil
Apr 23, 2024 02:21 PM